Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Chisy who wrote (1390)	8/10/1999 12:00:00 PM
From: Doug Bean	Read Replies (1) \| Respond to of 1837

Chisy: Well good for you in one way.. but why do you have to pay so much,, surely your insurance covers normal doctors prescriptions,, or are you in one of those "employers group " deals. Damn i hate them. My company offers a choice between them and our old Blue Cross program. After one year I opted out of the Employer plan and back into Blue Cross, ( $65 a month more but well worth it). I agree with your main point though and it is also nice to see that your doctor is so progressve and well informed. Good luck CRDoug

To: Chisy who wrote (1390)	8/10/1999 2:34:00 PM
From: muddphudd	Read Replies (1) \| Respond to of 1837

I think I see a similar problem here as the one that Cypress Bioscience is facing now (CYPB). CYPB got a new treatment for Rheumatoid Arthritis (RA) approved by the FDA earlier this year. It is a medical device that removed the harmful antibodies thought to play a role in RA (it is an auto-immune condition). The problem is that they are having a tough time penetrating the rheumatology market. Same for DuraMed. If they can't convince the docs that they should at least try Cenestin then it won't matter if they have the best drug on the market. I have a few friends who are drug reps for Pfizer and Organogenesis. They often mention how difficult it is to get docs to switch to a new med from an old med that they have been prescribing FOR YEARS. I hope DRMD can overcome this hurdle.